Arslan, Taner http://orcid.org/0000-0002-2388-1811
Pan, Yanbo http://orcid.org/0000-0001-9442-7782
Mermelekas, Georgios
Vesterlund, Mattias http://orcid.org/0000-0001-9471-6592
Orre, Lukas M.
Lehtiö, Janne http://orcid.org/0000-0002-8100-9562
Funding for this research was provided by:
Vetenskapsrådet (2019-04830)
Cancerfonden (CAN 2020/1269)
Stiftelsen för Strategisk Forskning (RIF14-0046)
Barncancerfonden (PR2019-0071)
Cancerföreningen i Stockholm (211243)
Stockholms Läns Landsting (2022-969446)
Article History
Received: 19 January 2021
Accepted: 18 March 2022
First Online: 22 June 2022
Competing interests
: J.L. reports receiving honoraria for invited speaker activities from Pfizer and Roche, institutional research support as a PI from AstraZeneca, Novartis and GE Healthcare. J.L. and L.M.O. are co-founders and shareholders of FenoMark Diagnostics AB.